0001209191-20-010479.txt : 20200219 0001209191-20-010479.hdr.sgml : 20200219 20200219160303 ACCESSION NUMBER: 0001209191-20-010479 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200214 FILED AS OF DATE: 20200219 DATE AS OF CHANGE: 20200219 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Becker Marc A. CENTRAL INDEX KEY: 0001618060 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36310 FILM NUMBER: 20629609 MAIL ADDRESS: STREET 1: 175 CROSSING BLVD. STREET 2: 4TH FLOOR CITY: FRAMINGHAM STATE: MA ZIP: 01702 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CONCERT PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001367920 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 65 HAYDEN AVENUE STREET 2: SUITE 3000N CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-860-0045 MAIL ADDRESS: STREET 1: 65 HAYDEN AVENUE STREET 2: SUITE 3000N CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: CONCERT PHARMACEUTICALS INC DATE OF NAME CHANGE: 20060628 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-02-14 0 0001367920 CONCERT PHARMACEUTICALS, INC. CNCE 0001618060 Becker Marc A. C/O CONCERT PHARMACEUTICALS, INC. 65 HAYDEN AVENUE, SUITE 3000N LEXINGTON MA 02421 0 1 0 0 Chief Financial Officer Common Stock 2020-02-14 4 A 0 28216 A 56309 D Stock Option (Right to Buy) 10.87 2020-02-14 4 A 0 42430 0.00 A 2030-02-13 Common Stock 42430 42430 D Each restricted stock unit ("RSU") represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs granted to Mr. Becker will vest in three equal annual installments measured from the date of grant. The number above represents the maximum number of shares that may be delivered pursuant to the award. Not applicable. The shares underlying this option vest in equal quarterly installments over a four-year period measured from the date of grant. /s/ Marc A. Becker 2020-02-19